AscellaHealth, based in Berwyn, Pennsylvania, extends its impactful operations across the United States and Europe, standing out as a critical player in the specialty pharmacy and healthcare services industry. This organization excels in offering customized, technologically advanced specialty pharmaceutical and medical management services. These services specifically target payers, providers, life sciences companies, and, notably, patients with complex chronic conditions or rare diseases that necessitate specialized medications and advanced therapeutic options.

Dea Belazi, serving as CEO and Co-founder, has played a pivotal role in molding AscellaHealth into a leading global entity in healthcare and specialty pharmacy solutions. Belazi's unique combination of extensive clinical knowledge as a registered pharmacist and strategic business acumen enables him to oversee and expand its diverse portfolio of services effectively. These services are crucial in aiding pharmaceutical manufacturers during the critical phases of launching and commercializing specialty and rare disease medications, aiming to improve patient outcomes significantly.

Alongside Belazi, Bill Oldham, as Chairman, President, and co-founder, brings his deep expertise in fintech to AscellaHealth. His innovative approach has significantly influenced the company's strategy, especially in the pharmacy benefit management (PBM) sector, positioning the company as a leader in the specialty pharmacy market. Oldham's leadership has driven the company to a remarkable 1556% growth in revenue over four years, achieved through a combination of organic growth and strategic acquisitions. His outstanding leadership has earned him various honors, including the Philadelphia Business Journal's 2022 CFO of the Year and inclusion in the Philadelphia Titan 100 for consecutive years.